Clearmind Medicine Inc. announced on June 18, 2026, that it has been granted a U.S. patent for its binge behavior regulators. This intellectual property protection covers the company's technology related to regulating binge behavior. Clearmind Medicine is a biopharmaceutical company focused on developing medicines for central nervous system disorders.
